AGILEX BIOLABS

As the premier Australian bioanalytical partner for COVID vaccine development, Agilex has completed multiple SARS-CoV-2 fast-track programs on behalf of its sponsors in the last two years, including mRNA, adenovirus, and molecular clamp stabilized protein subunit vaccines. In addition, Agilex is the only toxicology study provider in Australia to accommodate CAR-T therapy programs with immunocompromised models... Agilex Biolabs' team have extensive experience in successfully designing and executing regulatory toxicology studies for submission to various international regulatory bodies including FDA and EMA... Agilex has established a partnership throughout USA and APAC, making it easy for our clients to not have to choose between price, quality, and timelines. With this collaboration, our sponsors can fulfill the global requirement for two species for standard toxicology testing as stated in the international conference for hominization guidelines.

Also known as: Agilex